Suppr超能文献

高血压患者的尿激肽释放酶排泄及血浆多巴胺β-羟化酶活性

Urinary kallikrein excretion and plasma DBH activity in hypertension.

作者信息

Greco A V, Porcelli G, Magalhaes J F, Altomonte L

出版信息

Agents Actions. 1978 Dec;8(6):572-5. doi: 10.1007/BF01998885.

Abstract

Many factors are to be considered in maintaining normal blood pressure. Authors study the behavior of urinary kallikrein (U.K.) and plasma dopamine-beta-hydroxylase (DBH) activity in various forms of hypertension. The values of U.K. excretion in normals were 20.5 +/- 1.8 E.U./24 h. In essential hypertensive patients (9.4 +/- 2.0 E.U./24 h) U.K. decreased, while in secondary hypertension it was significantly higher (33.8 +/- 3.0 E.U./24 h). Plasma DBH activity in essential hypertensive patients (17.72 +/- 2.33 I.U./ml) was similar to controls (20.22 +/- 1.39 I.U./ml); in secondary hypertension the mean values of plasma DBH were decreased (12.31 +/- 2.55 I.U./ml). No correlation between U.K. and plasma DBH activity was observed in normals and in various forms of hypertensive patients. U.K. seems a more reliable factor than plasma DBH in defining the different types of hypertension.

摘要

维持正常血压需要考虑许多因素。作者研究了尿激肽释放酶(U.K.)的行为以及血浆多巴胺-β-羟化酶(DBH)活性在各种高血压类型中的情况。正常人尿激肽释放酶的排泄值为20.5±1.8国际单位/24小时。原发性高血压患者的尿激肽释放酶排泄值降低(9.4±2.0国际单位/24小时),而继发性高血压患者的排泄值显著升高(33.8±3.0国际单位/24小时)。原发性高血压患者的血浆DBH活性(17.72±2.33国际单位/毫升)与对照组(20.22±1.39国际单位/毫升)相似;继发性高血压患者血浆DBH的平均值降低(12.31±2.55国际单位/毫升)。在正常人和各种高血压患者中,未观察到尿激肽释放酶与血浆DBH活性之间存在相关性。在区分不同类型的高血压方面,尿激肽释放酶似乎比血浆DBH更可靠。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验